Posted on 17/05/2021
New York, USA, May 17, 2021 – RayOne Spheric, a fully-preloaded monofocal IOL, has received FDA approval. This achievement marks Rayner’s third FDA approval in under three years within its expanding RayOne preloaded IOL portfolio. RayOne Spheric joins RayOne Aspheric (FDA approved December 2018) and RayOne EMV, a new non-diffractive IOL solution which achieved FDA
Posted on 26/03/2021
New York, USA, March 26, 2021 – RayOne EMV, a new fully preloaded non-diffractive IOL, has received FDA approval. RayOne EMV was developed in collaboration with world renowned surgeon Professor Graham Barrett, president of the Australasian Society of Cataract & Refractive Surgeons. “I collaborated with Rayner on bringing to market RayOne EMV, an exciting
First Implantation of RayOne Aspheric Fully Preloaded IOL in United States Completed by Renowned Surgeon William F. Wiley, MD
Posted on 6/02/2019
NEW YORK, New York, February 01, 2019 – The first U.S. implantation of Rayner’s flagship RayOne Aspheric fully preloaded monofocal IOL (RAO600C) was successfully performed by William F. Wiley, MD at the Brecksville Surgery Center in Cleveland, Ohio following FDA approval in late 2018.